ArticleIJID regions2026
Resurgence of Chikungunya in Thailand.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Chikungunya is a re-emerging infectious disease in Thailand. We conducted this study to describe the epidemiological data of chikungunya infection in Thailand. Methods: The data of patients with chikungunya reported to the Center of Epidemiological Information, Bureau of Epidemiology, Ministry of Public Health, Thailand from January 2008 to December 2023 were analyzed. The diagnosis of chikungunya fever adhered to clinical and laboratory criteria. Results: From August 2008 onward, chikungunya cases were again reported in Thailand. The disease is more common during the rainy season, affecting all age groups. The strain in the current outbreak is African, which differs from the Asian strain of the past. The sudden onset of very high fever along with rash, and severe arthralgia, especially in the small joints of hands and toes, are characteristics of the disease. There was only one death case in 2020; however, the high morbidity with severe arthralgia persisting for several months weakened the patients mentally and physically. Conclusion: The implementation of effectively sustainable vector control is the key to success for prevention and control of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.